Dr. Cullen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-6841Fax+1 410-328-2578
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1986 - 1987
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1983 - 1986
- Harvard Medical SchoolClass of 1983
Certifications & Licensure
- MD State Medical License 1987 - 2026
- DC State Medical License 1988 - 2004
- VA State Medical License 2001 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
Publications & Presentations
PubMed
- Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC.Jipei Liao, Zejia Yang, Shirin Azarbarzin, Kevin J Cullen, Hancai Dan
Head & Neck. 2024-05-01 - Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric mo...Reza Zarinshenas, Peter Campbell, Kai Sun, Jason K Molitoris, Akshar N Patel
Radiotherapy and Oncology. 2024-04-01 - 2 citationsRegionalization of Head and Neck Oncology Tumor Boards: Perspectives of Collaborating Physicians.Neha B Amin, Kelly M Bridgham, Jessica P Brown, Kelly F Moyer, Rodney J Taylor
OTO Open. 2023-02-28
Press Mentions
- Dr. Kevin Cullen to Retire as Director of the University of Maryland Greenebaum Comprehensive Cancer Center in 2023January 17th, 2023
- Maryland Half Marathon and 5k Supports Cutting-Edge Research at University of Maryland Greenebaum Comprehensive Cancer CenterMay 26th, 2022
- Governor Hogan Announces Maryland Cancer Moonshot InitiativeMarch 31st, 2022
- Join now to see all
Grant Support
- Translational LaboratoryNational Cancer Institute2011
- Structural BiologyNational Cancer Institute2011
- Radiation Linear Shared ServiceNational Cancer Institute2011
- Protocol Specific ResearchNational Cancer Institute2011
- Protocol Review And Monitoring SystemNational Cancer Institute2011
- ProteomicsNational Cancer Institute2011
- Program LeadersNational Cancer Institute2011
- Planning And EvaluationNational Cancer Institute2011
- Pathology And BiorepositoryNational Cancer Institute2011
- Genomics - Shared ServicesNational Cancer Institute2011
- Flow CytometryNational Cancer Institute2011
- Data And Safety MonitoringNational Cancer Institute2011
- Clinical Research Shared ServicesNational Cancer Institute2011
- Biostatistics Shared ServiceNational Cancer Institute2011
- Animals Shared ServiceNational Cancer Institute2011
- AdministrationNational Cancer Institute2011
- University Of Maryland Greenebaum Cancer Center Support GrantNational Cancer Institute2008–2011
- Senior LeadershipNational Cancer Institute2008–2011
- Developmental FundsNational Cancer Institute2008–2011
- Program And Planning And EvaluationNational Cancer Institute2008–2010
- Prognostic Markers In Trials For Head And Neck CancerNational Cancer Institute2004–2005
- AP4 Planning For Targeted Drugs In Orphan CancersNational Cancer Institute2004
- Greenbaum Cancer Center, University Of MarylandNational Cancer Institute2001–2004
- Prognostic Markers In Trials For Head And Neck CancerNational Cancer Institute2003
- Midcareer Investigator AwardNational Cancer Institute2003
- Midcareer Investigator AwardNational Cancer Institute1999–2003
- Cancer Center Support GrantNational Cancer Institute2001–2002
- Clinical Oncology Research Career Development ProgramNational Cancer Institute2000–2002
- Insulin LIKE Growth Factor II In Breast CancerNational Cancer Institute1997–1999
- Predicting Chemotherapy Response In Head And Neck CancerNational Cancer Institute1997–1998
- Stromal/Epithelial Interactions In Breast CancerNational Cancer Institute1995
- Insulin-Like Growth Factor II In Breast CancerNational Cancer Institute1993–1995
- Stromal-Epithelial Interactions In Breast CancerNational Cancer Institute1991–1995
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: